×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Lotus Eye Hospital and Institute Limited | 137.85 | -2.61 | 135.5 | -0.13 | 246.0 | 378.0 |
| Aarey Drugs & Pharmaceuticals Limited | 1006.08 | 12.78 | 964.26 | 0.2 | 223 | 53.5 |
| Pharmaids Pharmaceuticals Ltd | 55.06 | -26.46 | 54.30 | NA | 204 |
Lotus Eye Hospital And Institute Limited, with Security Code 532998, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12.9 | 12.9 | 12.2 | 11.5 | 13.5 | 13.0 | 13.6 | 13.6 |
| Expenses | 11.2 | 11.8 | 11.5 | 10.4 | 12.0 | 12.3 | 12.9 | 12.9 |
| Operating Profit | 1.7 | 1.1 | 0.8 | 1.1 | 1.5 | 0.8 | 0.7 | 0.7 |
| OPM % | 12.92% | 8.88% | 6.44% | 9.47% | 10.93% | 5.91% | 4.84% | 4.84% |
| Other Income | 0.3 | 0.3 | 0.2 | 0.5 | 0.2 | 0.3 | 0.2 | 0.2 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 |
| Depreciation | 1.1 | 1.2 | 1.3 | 0.6 | 0.8 | 0.8 | 1.0 | 1.0 |
| Profit before tax | 0.9 | 0.1 | -0.4 | 0.9 | 0.7 | 0.1 | -0.4 | -0.4 |
| Tax % | 27.2% | 6.4% | 43.9% | -59.4% | 25.3% | -58.9% | 30.4% | 30.4% |
| Net Profit | 0.6 | 0.1 | -0.2 | 0.3 | 0.5 | 0.1 | -0.3 | -0.3 |
| EPS in Rs | 0.3 | 0.05 | -0.11 | 0 | 0.26 | 0.06 | -0.13 | -0.13 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | 14% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 54% |
| 5 Years: | 33% |
| 3 Years: | 24% |
| TTM: | -86% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 24% |
| 3 Years: | 12% |
| 1 Year: | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|